1. Duplaquet, Leslie, So, Kevin, Ying, Alexander W, Kadoch, Cigall, Oser, Matthew G. 2024. Mammalian SWI/SNF complex activity regulates POU2F3 and constitutes a targetable dependency in small cell lung cancer. In Cancer cell, 42, 1352-1369.e13. doi:10.1016/j.ccell.2024.06.012. https://pubmed.ncbi.nlm.nih.gov/39029464/
2. Adduri, Raju S R, George, Sara A, Kavadipula, Padmavathi, Bashyam, Murali D. 2019. SMARCD1 is a transcriptional target of specific non-hotspot mutant p53 forms. In Journal of cellular physiology, 235, 4559-4570. doi:10.1002/jcp.29332. https://pubmed.ncbi.nlm.nih.gov/31637714/
3. Priam, Pierre, Krasteva, Veneta, Rousseau, Philippe, Kmita, Marie, Lessard, Julie A. 2024. Smarcd1 subunit of SWI/SNF chromatin-remodeling complexes collaborates with E2a to promote murine lymphoid specification. In Developmental cell, 59, 3124-3140.e8. doi:10.1016/j.devcel.2024.08.007. https://pubmed.ncbi.nlm.nih.gov/39232562/
4. Ross, Christina, Gong, Li-Yun, Jenkins, Lisa M, Majocha, Megan, Hunter, Kent. 2024. SMARCD1 is a "Goldilocks" metastasis modifier. In bioRxiv : the preprint server for biology, , . doi:10.1101/2024.01.24.577061. https://pubmed.ncbi.nlm.nih.gov/38410477/
5. Inoue, Chisato, Zhao, Chong, Tsuduki, Yumi, Nomura, Masatoshi, Katakura, Yoshinori. 2017. SMARCD1 regulates senescence-associated lipid accumulation in hepatocytes. In NPJ aging and mechanisms of disease, 3, 11. doi:10.1038/s41514-017-0011-1. https://pubmed.ncbi.nlm.nih.gov/28868154/
6. Chen, Jiaoquan, Yu, Nanji, Ou, Shanshan, Li, Huaping, Zhu, Huilan. 2023. Integrated analysis reveals SMARCD1 is a potential biomarker and therapeutic target in skin cutaneous melanoma. In Journal of cancer research and clinical oncology, 149, 11619-11634. doi:10.1007/s00432-023-05064-8. https://pubmed.ncbi.nlm.nih.gov/37401939/
智鼠故事 
